T45.AX5 Categoria · é necessária maior especificidade Adverse effect of immune checkpoint inhibitors and immunostimulant drugs
ICD-10-CM T45.AX5 identifies “Adverse effect of immune checkpoint inhibitors and immunostimulant drugs” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 19: Injury, poisoning and certain other consequences of external causes
Instruções do código
Sem notas adicionais.
Instruções dos níveis superiores
Capítulos 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T45 · Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
Seventh character1
The appropriate 7th character is to be added to each code from category T45
A — initial encounter
D — subsequent encounter
S — sequela
T45.A · Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs
Excludes 11
poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drug (T45.1)
Códigos mais específicos
T45.AX5AAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounterCódigo faturável e específicoT45.AX5DAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounterCódigo faturável e específicoT45.AX5SAdverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequelaCódigo faturável e específicoReferências do índice oficial
Referências do índice oficial (2)
Immune (1)
- Immune › checkpoint inhibitorsMedicamentos e substâncias químicas
Immunostimulant drug (1)
- Immunostimulant drugMedicamentos e substâncias químicas
Referências de outros códigos (2)
Use additional code · code for adverse effect, if applicable, to identify immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
Excludes 2 · adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
Histórico
Histórico do código
Última alteração registrada · FY2025 · 04-01
Válido a partir de
- Instruções herdadas alteradas
Adverse effect of immune checkpoint inhibitors and immunostimulant drugs
Categoria — selecione um código mais específico
CDC/NCHS · FY2025 · 04-01Todas as edições (5)
| Todas as edições | Válido a partir de | Histórico do código |
|---|---|---|
| FY2025 | 2024-10-01 | Adicionado |
| FY2025 · 04-01 | 2025-04-01 | Instruções herdadas alteradas |
| FY2026 | 2025-10-01 | Sem alteração tabular |
| FY2026 · April | 2026-04-01 | Sem alteração tabular |
| FY2027 | 2026-10-01 | Sem alteração tabular |
Explore os códigos mais específicos desta categoria. A verificação da referência não estabelece adequação clínica nem garante reembolso.